TLR4-IN-C34 (or C34) is a drug which acts as a potent and selective antagonist of Toll-like receptor 4 (TLR4).

In animal studies it blocks TLR4-mediated cytokine release and has antiinflammatory effects.

[1][2][3][4][5]

This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.